Insiders Updates
SUPN’s latest rating updates from top analysts.
Supernus Pharmaceuticals Inc’s recently made public that its President, CEO Khattar Jack A. unloaded Company’s shares for reported $91506.0 on
Menu
Supernus Pharmaceuticals Inc’s recently made public that its President, CEO Khattar Jack A. unloaded Company’s shares for reported $91506.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Supernus Pharmaceuticals
In a filing, Supernus Pharmaceuticals Inc revealed its President, CEO Khattar Jack A. unloaded Company’s shares for reported $0.78 million
In a filing, Supernus Pharmaceuticals Inc revealed its SVP, Chief Tech. Ops. Officer Mottola Frank unloaded Company’s shares for reported
Supernus Pharmaceuticals Inc’s recently made public that its President, CEO Khattar Jack A. unloaded Company’s shares for reported $2.56 million
Supernus Pharmaceuticals Inc’s filing revealed that its President, CEO Khattar Jack A. unloaded Company’s shares for reported $1.09 million on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Supernus Pharmaceuticals Inc’s filing revealed that its Director Sensenig Bethany unloaded Company’s shares for reported $0.23 million on Aug 14
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Supernus Pharmaceuticals
Supernus Pharmaceuticals Inc’s recently made public that its President, CEO Khattar Jack A. unloaded Company’s shares for reported $5.88 million